Stevens Professor Joins Open Source Effort to Develop Low-Cost Drugs
Summary
Ganguly of the Department of Chemistry, Chemical Biology & Biomedical Engineering at Stevens Institute of Technology is contributing his expertise and passion to the Council of Scientific and Industrial Research (CSIR) Open Source Drug Discovery initiative.Hoboken, NJ, March 16, 2013 --( “Malaria and tuberculosis are two of the world’s deadliest infectious diseases, killing over 2 million people combined in 2010, the vast majority of whom live in developing nations,” says Dr. Michael Bruno, Dean of the Charles V. Schaefer, Jr. School of Engineering and Science.In order to assist in the effort to develop novel affordable treatments for diseases that exceedingly affect lower and middle-income countries, Dr. Ganguly will serve as a mentor to the CSIR-led global initiative Open Source Drug Discovery (OSDD).Ganguly of the Department of Chemistry, Chemical Biology & Biomedical Engineering at Stevens Institute of Technology is contributing his expertise and passion to the Council of Scientific and Industrial Research (CSIR) Open Source Drug Discovery initiative.Emerging drug-resistant strains exacerbate the problem.In order to assist in the effort to develop novel affordable treatments for diseases that exceedingly affect lower and middle-income countries, Dr. Ganguly will serve as a mentor to the CSIR-led global initiative Open Source Drug Discovery (OSDD).